Review



aldehyde group–based microarray slide  (CapitalBio Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    CapitalBio Corporation aldehyde group–based microarray slide
    Schematic representation of the 24 ATP7B loci and the arrangement of probes in the WD <t>microarray.</t>
    Aldehyde Group–Based Microarray Slide, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aldehyde group–based microarray slide/product/CapitalBio Corporation
    Average 90 stars, based on 1 article reviews
    aldehyde group–based microarray slide - by Bioz Stars, 2026-06
    90/100 stars

    Images

    1) Product Images from "Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China"

    Article Title: Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China

    Journal: Journal of Clinical Laboratory Analysis

    doi: 10.1002/jcla.24735

    Schematic representation of the 24 ATP7B loci and the arrangement of probes in the WD microarray.
    Figure Legend Snippet: Schematic representation of the 24 ATP7B loci and the arrangement of probes in the WD microarray.

    Techniques Used: Microarray

    List of ATP7B mutations selected for microarray detection.
    Figure Legend Snippet: List of ATP7B mutations selected for microarray detection.

    Techniques Used: Microarray, Mutagenesis

    Determination of cut‐off value for the 24 loci of ATP7B mutation by the microarray detection.
    Figure Legend Snippet: Determination of cut‐off value for the 24 loci of ATP7B mutation by the microarray detection.

    Techniques Used: Mutagenesis, Microarray

    Representative result of multiplex asymmetric PCR and microarray detection. (A) Twelve bands of PCR products covering all detection sites are distributed in three tubes. The length of the bands and the target fragments in the three tubes are as follows: Tube 1, 287 bp (p.Y741C, p.D765G, p.R778L/Q), 250 bp (p.N1270S, p.T1286I), 172 bp (p.L692P), 137 bp (p.I1148T, p.E1173K); tube 2, 248 bp (p.R919G, p.T935M, p.G943D, p.G948C), 212 bp (p.G869R, p.A874V, p.T888P), 166 bp (p.S975Y, p.G1000R), 130 bp (p.V1106I); and tube 3, 260 bp (p.D196E, p.G250R), 226 bp (p.C490X), 196 bp (c.1708‐5 T>G, p.I592F), and 84 bp (p.I1230T). (B) A representative genotyping result of a clinical sample by microarray detection.
    Figure Legend Snippet: Representative result of multiplex asymmetric PCR and microarray detection. (A) Twelve bands of PCR products covering all detection sites are distributed in three tubes. The length of the bands and the target fragments in the three tubes are as follows: Tube 1, 287 bp (p.Y741C, p.D765G, p.R778L/Q), 250 bp (p.N1270S, p.T1286I), 172 bp (p.L692P), 137 bp (p.I1148T, p.E1173K); tube 2, 248 bp (p.R919G, p.T935M, p.G943D, p.G948C), 212 bp (p.G869R, p.A874V, p.T888P), 166 bp (p.S975Y, p.G1000R), 130 bp (p.V1106I); and tube 3, 260 bp (p.D196E, p.G250R), 226 bp (p.C490X), 196 bp (c.1708‐5 T>G, p.I592F), and 84 bp (p.I1230T). (B) A representative genotyping result of a clinical sample by microarray detection.

    Techniques Used: Multiplex Assay, Microarray

    Results of microarray detection of ATP7B mutation in 106 suspected WD cases and comparison with that by sequencing.
    Figure Legend Snippet: Results of microarray detection of ATP7B mutation in 106 suspected WD cases and comparison with that by sequencing.

    Techniques Used: Microarray, Mutagenesis, Sequencing

    Schematic representation of the prevalence of individual ATP7B mutations in Chinese WD patients as detected by the microarray method. p.R778L (50.94%), p.A874V (17.92%), p.P992L (11.32%), p.V1106I (11.32%), and p.I1148T (6.60%) were the most common mutations. ATP7B p.P992L was identified by sequencing.
    Figure Legend Snippet: Schematic representation of the prevalence of individual ATP7B mutations in Chinese WD patients as detected by the microarray method. p.R778L (50.94%), p.A874V (17.92%), p.P992L (11.32%), p.V1106I (11.32%), and p.I1148T (6.60%) were the most common mutations. ATP7B p.P992L was identified by sequencing.

    Techniques Used: Microarray, Sequencing



    Similar Products

    aldehyde group–based microarray slide  (CapitalBio Corporation)
    90
    CapitalBio Corporation aldehyde group–based microarray slide
    Schematic representation of the 24 ATP7B loci and the arrangement of probes in the WD <t>microarray.</t>
    Aldehyde Group–Based Microarray Slide, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aldehyde group–based microarray slide/product/CapitalBio Corporation
    Average 90 stars, based on 1 article reviews
    aldehyde group–based microarray slide - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Schematic representation of the 24 ATP7B loci and the arrangement of probes in the WD microarray.

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China

    doi: 10.1002/jcla.24735

    Figure Lengend Snippet: Schematic representation of the 24 ATP7B loci and the arrangement of probes in the WD microarray.

    Article Snippet: Probes were then spotted on the surface of the aldehyde group–based microarray slide (CapitalBio) using a PersonalArrayer™ 16 spotting instrument (CapitalBio).

    Techniques: Microarray

    List of ATP7B mutations selected for microarray detection.

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China

    doi: 10.1002/jcla.24735

    Figure Lengend Snippet: List of ATP7B mutations selected for microarray detection.

    Article Snippet: Probes were then spotted on the surface of the aldehyde group–based microarray slide (CapitalBio) using a PersonalArrayer™ 16 spotting instrument (CapitalBio).

    Techniques: Microarray, Mutagenesis

    Determination of cut‐off value for the 24 loci of ATP7B mutation by the microarray detection.

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China

    doi: 10.1002/jcla.24735

    Figure Lengend Snippet: Determination of cut‐off value for the 24 loci of ATP7B mutation by the microarray detection.

    Article Snippet: Probes were then spotted on the surface of the aldehyde group–based microarray slide (CapitalBio) using a PersonalArrayer™ 16 spotting instrument (CapitalBio).

    Techniques: Mutagenesis, Microarray

    Representative result of multiplex asymmetric PCR and microarray detection. (A) Twelve bands of PCR products covering all detection sites are distributed in three tubes. The length of the bands and the target fragments in the three tubes are as follows: Tube 1, 287 bp (p.Y741C, p.D765G, p.R778L/Q), 250 bp (p.N1270S, p.T1286I), 172 bp (p.L692P), 137 bp (p.I1148T, p.E1173K); tube 2, 248 bp (p.R919G, p.T935M, p.G943D, p.G948C), 212 bp (p.G869R, p.A874V, p.T888P), 166 bp (p.S975Y, p.G1000R), 130 bp (p.V1106I); and tube 3, 260 bp (p.D196E, p.G250R), 226 bp (p.C490X), 196 bp (c.1708‐5 T>G, p.I592F), and 84 bp (p.I1230T). (B) A representative genotyping result of a clinical sample by microarray detection.

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China

    doi: 10.1002/jcla.24735

    Figure Lengend Snippet: Representative result of multiplex asymmetric PCR and microarray detection. (A) Twelve bands of PCR products covering all detection sites are distributed in three tubes. The length of the bands and the target fragments in the three tubes are as follows: Tube 1, 287 bp (p.Y741C, p.D765G, p.R778L/Q), 250 bp (p.N1270S, p.T1286I), 172 bp (p.L692P), 137 bp (p.I1148T, p.E1173K); tube 2, 248 bp (p.R919G, p.T935M, p.G943D, p.G948C), 212 bp (p.G869R, p.A874V, p.T888P), 166 bp (p.S975Y, p.G1000R), 130 bp (p.V1106I); and tube 3, 260 bp (p.D196E, p.G250R), 226 bp (p.C490X), 196 bp (c.1708‐5 T>G, p.I592F), and 84 bp (p.I1230T). (B) A representative genotyping result of a clinical sample by microarray detection.

    Article Snippet: Probes were then spotted on the surface of the aldehyde group–based microarray slide (CapitalBio) using a PersonalArrayer™ 16 spotting instrument (CapitalBio).

    Techniques: Multiplex Assay, Microarray

    Results of microarray detection of ATP7B mutation in 106 suspected WD cases and comparison with that by sequencing.

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China

    doi: 10.1002/jcla.24735

    Figure Lengend Snippet: Results of microarray detection of ATP7B mutation in 106 suspected WD cases and comparison with that by sequencing.

    Article Snippet: Probes were then spotted on the surface of the aldehyde group–based microarray slide (CapitalBio) using a PersonalArrayer™ 16 spotting instrument (CapitalBio).

    Techniques: Microarray, Mutagenesis, Sequencing

    Schematic representation of the prevalence of individual ATP7B mutations in Chinese WD patients as detected by the microarray method. p.R778L (50.94%), p.A874V (17.92%), p.P992L (11.32%), p.V1106I (11.32%), and p.I1148T (6.60%) were the most common mutations. ATP7B p.P992L was identified by sequencing.

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China

    doi: 10.1002/jcla.24735

    Figure Lengend Snippet: Schematic representation of the prevalence of individual ATP7B mutations in Chinese WD patients as detected by the microarray method. p.R778L (50.94%), p.A874V (17.92%), p.P992L (11.32%), p.V1106I (11.32%), and p.I1148T (6.60%) were the most common mutations. ATP7B p.P992L was identified by sequencing.

    Article Snippet: Probes were then spotted on the surface of the aldehyde group–based microarray slide (CapitalBio) using a PersonalArrayer™ 16 spotting instrument (CapitalBio).

    Techniques: Microarray, Sequencing